Genotypic and Phenotypic Characterization of Virologic Failure through 48 Weeks Among Treatment-Naïve Patients Taking Tenofovir DF or Stavudine in Combination with Lamivudine and Efavirenz

MD Miller, NA Margot, DJ McColl*, S Tran, DF Coakley, and AK Cheng

Next slide

Back to first slide

View graphic version